Article Details

In Brief This Week: AstraZeneca, Merck, Stemline Therapeutics, Caris Life Sciences, Artios Pharma

Retrieved on: 2022-08-12 16:48:20

Tags for this article:

Click the tags to see associated articles and topics

In Brief This Week: AstraZeneca, Merck, Stemline Therapeutics, Caris Life Sciences, Artios Pharma. View article details on HISWAI: https://www.precisiononcologynews.com/regulatory-news-fda-approvals/brief-week-astrazeneca-merck-stemline-therapeutics-caris-life

Excerpt

NEW YORK – Health Canada this week approved AstraZeneca and Merck's PARP inhibitor Lynparza (olaparib) as adjuvant treatment for high-risk, ...

Article found on: www.precisiononcologynews.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up